The ex-pharma exec leading Trump's COVID-19 vaccine program has $10 million in stock options for a company getting federal funding

"It is a huge conflict of interest for the White House's new vaccine czar to own $10 million of stock in a company receiving government funding to develop a COVID-19 vaccine. Dr. Slaoui should divest immediately.

Continue...